BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9725048)

  • 41. Clinical impact of thymidine phosphorylase expression in gastric cancer.
    Noguchi T; Fujiwara S; Takeno S; Kai S; Mizuta A; Nagao Y; Uchida Y
    Oncol Rep; 2003; 10(3):561-6. PubMed ID: 12684624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of the pharmacokinetics of 5'-deoxy-5-fluorouridine and 5-fluorouracil in rats by oral co-administration of acyclothymidine.
    Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1996 May; 19(5):729-32. PubMed ID: 8741584
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of pyrimidine nucleoside phosphorylase enhances the sensitivity to 5'-deoxy-5-fluorouridine in tumour cells in vitro and in vivo.
    Nagata T; Nakamori M; Iwahashi M; Yamaue H
    Eur J Cancer; 2002 Mar; 38(5):712-7. PubMed ID: 11916555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
    Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
    Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Kobayashi T; Kimura T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1521-6. PubMed ID: 11015996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymidine phosphorylase expressed in macrophages enhances antitumor effect of 5'-deoxy-5-fluorouridine on human colorectal carcinoma cells.
    Zhang J; Mizoi T; Harada N; Shiiba K; Miyagawa K; Matsuno S; Sasaki I
    Anticancer Res; 2003; 23(1A):323-9. PubMed ID: 12680231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acyclothymidine alleviates intestinal toxicity of 5'-deoxy-5-fluorouridine without loss of antitumor activity in mice.
    Hamada A; Fukushima S; Saneyoshi M; Shimizu S; Kawaguchi T; Nakano M
    Biol Pharm Bull; 1996 Oct; 19(10):1362-6. PubMed ID: 8913513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.
    Patterson AV; Zhang H; Moghaddam A; Bicknell R; Talbot DC; Stratford IJ; Harris AL
    Br J Cancer; 1995 Sep; 72(3):669-75. PubMed ID: 7669579
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
    Fujimoto K; Matsumura Y; Tani Y; Ozono S; Hirao Y; Okajima E
    Int J Urol; 2007 Aug; 14(8):754-9. PubMed ID: 17681069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients.
    Ohwada S; Ogawa T; Izumi M; Inoue T; Teshigawara O; Ikeya T; Kusaba T; Roppongi T; Iino Y; Morishita Y
    Anticancer Res; 1997; 17(3C):2313-8. PubMed ID: 9216708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Significance of pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase levels to predict postoperative recurrence in primary breast cancer].
    Tamesa M; Yamamoto S; Maeda N; Nagashima Y; Oka M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):431-6. PubMed ID: 18347391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic effect of PyNPase (pyrimidine nucleoside phosphorylase) activity in breast cancer].
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Yamashita H; Fukuda M; Higuchi A; Masuyama S; Uchino S; Matsumoto H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):59-66. PubMed ID: 9464330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
    Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
    Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhancement of drug sensitivity and a bystander effect in PC-9 cells transfected with a platelet-derived endothelial cell growth factor thymidine phosphorylase cDNA.
    Kato Y; Matsukawa S; Muraoka R; Tanigawa N
    Br J Cancer; 1997; 75(4):506-11. PubMed ID: 9052401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Ishitsuka H; Miwa M; Takemoto K; Fukuoka K; Itoga A; Maruyama HB
    Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
    Ogata Y; Matono K; Sasatomi T; Ishibashi N; Torigoe S; Fukumitsu T; Mizobe T; Yamashita N; Yanagawa T; Shirouzu K
    J Surg Oncol; 2006 Jan; 93(1):47-55. PubMed ID: 16353181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Influences of 5'-deoxy-5-fluorouridine (5'-DFUR) on cell cycle in patients with breast cancer].
    Kimura T; Muraki H; Kamio T; Katoh T; Fujii A; Yamamoto K; Hamano K
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):816-20. PubMed ID: 8489292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Distributions of pyrimidine nucleoside phosphorylase (PyNPase) in tissues of benign and malignant mammary diseases--immunohistochemical observations].
    Fukada D; Saji S; Kawaguchi Y; Nagata M; Shimokawa K; Furuta T
    Gan To Kagaku Ryoho; 1996 May; 23(6):703-6. PubMed ID: 8645021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Two patients with liver metastasis from gastric cancer who responded remarkably to combined therapy of 5'-DFUR and PSK].
    Kitamura M; Umekita N; Inoue S; Miyamoto Y; Maeshiro T; Saiura A; Tanaka S; Kawahara Y; Arai K; Iwasaki Y; Ohashi M; Takahashi T
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1737-41. PubMed ID: 11057326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.